Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S, Mick R, Xu F, Stonys E, Le Beau MM, Larson R, Vardiman JW.
Leukemia. 1996 Jan;10(1):20-6.
PMID:8558932
Myelodysplastic syndromes: prognostic significance of multilineage dysplasia in patients with refractory anemia or refractory anemia with ringed sideroblasts.
Dunkley SM, Manoharan A, Kwan YL.
Blood. 2002 May 15;99(10):3870-1; author reply 3871. doi: 10.1182/blood-2001-11-0120.
PMID:12014369
The WHO classification of MDS does make a difference.
Howe RB, Porwit-MacDonald A, Wanat R, Tehranchi R, Hellström-Lindberg E.
Blood. 2004 May 1;103(9):3265-70. doi: 10.1182/blood-2003-06-2124. Epub 2003 Dec 18.
PMID:14684416
Prospective validation of the WHO proposals for the classification of myelodysplastic syndromes.
Germing U, Strupp C, Kuendgen A, Isa S, Knipp S, Hildebrandt B, Giagounidis A, Aul C, Gattermann N, Haas R.